Loading company…
Norwegian Pronova BioPharma develops and makes omega-3 solutions for pharmaceutical and nutritional markets, including Omacor.
Founded in 1935 and headquartered in Norway, Pronova BioPharma develops omega-3 products, including the Omacor drug launched in 1994. It supplies omega-3 ethyl esters and triglyceride concentrates to pharmaceutical and nutritional companies in nearly 70 countries, on a B2B basis. In 2019 it reported revenue of EUR 135,921,174 and EBITDA of EUR 39,753,738. BASF The Chemical Company acquired it in November 2012 in a trade sale of EUR 664.00 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in